Overview

Evaluation of the Efficacy and Safety of LevoCept

Status:
Completed
Trial end date:
2020-11-12
Target enrollment:
Participant gender:
Summary
To evaluate the effectiveness, device placement, safety, and tolerability of LevoCept to support commencing a Phase III Clinical Study
Phase:
Phase 2
Details
Lead Sponsor:
ContraMed LLC
Sebela Pharmaceuticals Inc.
Collaborators:
Synteract, Inc.
SynteractHCR
Treatments:
Levonorgestrel